Do we have any alternative therapeutic option beyond antibiotics? Tobias Welte (Hannover, Germany)
|   |
The role on new anti-infectives in the era of EID Burcu Isler (Herston, Australia)
|  |
COVID-19 vaccination and more A. Yorgancioglu (Konak, Turkey), J. Chorostowska (Warsaw, Poland), T. Welte (Hannover, Germany), M. Akova (Ankara, Turkey), A. Sayiner (Izmir, Turkey)
Thursday, 05 November 2021 |   |
Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy Maria Di Cicco, Ester Del Tufo, Eva Parolo, Mariacristina Menconi, Sayla Bernasconi, Chiara Romei, Alessandro Di Gangi, Beatrice Masini, Diego Peroni, Gabriella Casazza ERJ Open Res, 7 (3) 00407-2021; 10.1183/23120541.00407-2021 |    |
Implementing and evaluating standardised tuberculosis incident management for nonhousehold contacts in a large clinical network Benjamin Patterson, Narinder Boparai, Jennifer Dekoningh, Sudy Anaraki, Jacqui White, Marc Lipman ERJ Open Res, 7 (3) 00270-2021; 10.1183/23120541.00270-2021 |    |
Latent tuberculosis infection among contacts of patients with multidrug-resistant tuberculosis in New South Wales, Australia Vicky Chang, Raphael Hongxi Ling, Kavindhran Velen, Greg J. Fox ERJ Open Res, 7 (3) 00149-2021; 10.1183/23120541.00149-2021 |    |
The risk of community-acquired pneumonia in children using gastric acid suppressants Linda J.T.M. van der Sande, Quirijn Jöbsis, Michiel A.G.E. Bannier, Ewoudt M.W. van de Garde, Jan J.M. Coremans, Frank de Vries, Edward Dompeling, Johanna H.M. Driessen Eur Respir J, 58 (4) 2003229; 10.1183/13993003.03229-2020 |    |
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial Kay Wang, Malcolm G. Semple, Michael Moore, Alastair D. Hay, Sharon Tonner, Ushma Galal, Jenna Grabey, Tricia Carver, Rafael Perera, Ly-Mee Yu, Jill Mollison, Paul Little, Andrew Farmer, Christopher C. Butler, Anthony Harnden Eur Respir J, 58 (4) 2002819; 10.1183/13993003.02819-2020 |    |
Understanding the impact of the lung microenvironment to enhance the therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome Claire Masterson, Hector Gonzalez, John G. Laffey Eur Respir J, 58 (4) 2100986; 10.1183/13993003.00986-2021 |    |
IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD Holly R. Keir, James D. Chalmers Eur Respir J, 58 (4) 2102143; 10.1183/13993003.02143-2021 |    |
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021 |    |
Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems Simone Villa, Elisa Tagliani, Emanuele Borroni, Paola Francesca Castellotti, Maurizio Ferrarese, Arash Ghodousi, Anna Lamberti, Sabrina Senatore, Marino Faccini, Daniela Maria Cirillo, Luigi Ruffo Codecasa Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021 |    |
Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe Antoni Noguera-Julian, Danilo Buonsenso, Lindsay McKenna, James A. Seddon, Nicole Ritz Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021 |    |
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann, Christoph Lange Eur Respir J, 58 (3) 2003492; 10.1183/13993003.03492-2020 |    |
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness I. Sau (Sutton Coldfield, United Kingdom)
|  |
Prophylaxis against respiratory syncytial virus in high-risk infants Luca Bonadies, Elena Priante, Eugenio Baraldi Eur Respir Monogr 2021; 92: 361-371 |   |
Newborn lung diseases in low- and middle-income countries Olukemi O. Tongo, Zainab O. Imam Eur Respir Monogr 2021; 92: 343-349 |   |
Congenital infections of the respiratory tract Sarah Primhak, Evangelia Myttaraki, Elizabeth Whittaker Eur Respir Monogr 2021; 92: 245-258 |   |
Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study Divya Anthwal, Rakesh Kumar Gupta, Ritu Singhal, Manpreet Bhalla, Ajoy Kumar Verma, Khalid Umar Khayyam, Vithal Prasad Myneedu, Rohit Sarin, Ashawant Gupta, Nalini Kant Gupta, Manjula Singh, Jaya Sivaswami Tyagi, Sagarika Haldar ERJ Open Res, 7 (3) 00137-2021; 10.1183/23120541.00137-2021 |    |
International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives June K. Marthin, Jane S. Lucas, Mieke Boon, Carmen Casaulta, Suzanne Crowley, Damien M.S. Destouches, Ernst Eber, Amparo Escribano, Eric Haarman, Claire Hogg, Bernard Maitre, Gemma Marsh, Vendula Martinu, Antonio Moreno-Galdó, Huda Mussaffi, Heymut Omran, Petr Pohunek, Bernhard Rindlisbacher, Phil Robinson, Deborah Snijders, Woolf T. Walker, Panayiotis Yiallouros, Helle Krogh Johansen, Kim G. Nielsen ERJ Open Res, 7 (3) 00301-2021; 10.1183/23120541.00301-2021 |    |
Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea Soo Han Kim, Young Ju Jung, Myung-Su Ko, Sei Won Lee, Jae Seung Lee, Yeon-Mok Oh ERJ Open Res, 7 (3) 00188-2021; 10.1183/23120541.00188-2021 |    |
Impact of the revised definition of extensively drug-resistant tuberculosis Nicolas Veziris, Isabelle Bonnet, Florence Morel, Lorenzo Guglielmetti, Thomas Maitre, Laure Fournier Le Ray, Wladimir Sougakoff, Jérôme Robert, Alexandra Aubry Eur Respir J, 58 (2) 2100641; 10.1183/13993003.00641-2021 |    |
Framework for the evaluation of new tests for tuberculosis infection Yohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, Adam Penn-Nicholson, Morten Ruhwald, Dick Menzies, Olivia Oxlade, Dennis Falzon, Avinash Kanchar, Alexei Korobitsyn, Matteo Zignol, Alberto Matteelli, Tereza Kasaeva Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020 |    |
Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism Yan Hui Giam, Amelia Shoemark, James D. Chalmers Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020 |    |
Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease Ho Namkoong, Yosuke Omae, Takanori Asakura, Makoto Ishii, Shoji Suzuki, Kozo Morimoto, Yosuke Kawai, Katsura Emoto, Andrew J. Oler, Eva P. Szymanski, Mitsunori Yoshida, Shuichi Matsuda, Kazuma Yagi, Isano Hase, Tomoyasu Nishimura, Yuka Sasaki, Takahiro Asami, Tetsuya Shiomi, Hiroaki Matsubara, Hisato Shimada, Junko Hamamoto, Byung Woo Jhun, Su-Young Kim, Hee Jae Huh, Hong-Hee Won, Manabu Ato, Kenjiro Kosaki, Tomoko Betsuyaku, Koichi Fukunaga, Atsuyuki Kurashima, Hervé Tettelin, Hideki Yanai, Surakameth Mahasirimongkol, Kenneth N. Olivier, Yoshihiko Hoshino, Won-Jung Koh, Steven M. Holland, Katsushi Tokunaga, Naoki Hasegawa Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019 |    |
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial Esther Wittermans, Stefan M.T. Vestjens, Simone M.C. Spoorenberg, Willem L. Blok, Jan C. Grutters, Rob Janssen, Ger T. Rijkers, Frank W.J.M. Smeenk, G. Paul Voorn, Ewoudt M.W. van de Garde, Willem Jan W. Bos Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020 |    |
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Thomas Maitre, Jonathan Cottenet, Cendrine Godet, Adrien Roussot, Nafiz Abdoul Carime, Vichita Ok, Antoine Parrot, Philippe Bonniaud, Catherine Quantin, Jacques Cadranel Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 |    |
European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis Anne B. Chang, Rebecca Fortescue, Keith Grimwood, Efthymia Alexopoulou, Leanne Bell, Jeanette Boyd, Andrew Bush, James D. Chalmers, Adam T. Hill, Bulent Karadag, Fabio Midulla, Gabrielle B. McCallum, Zena Powell, Deborah Snijders, Woo-Jung Song, Thomy Tonia, Christine Wilson, Angela Zacharasiewicz, Ahmad Kantar Eur Respir J, 58 (2) 2002990; 10.1183/13993003.02990-2020 |    |
World Health Organization treatment outcome definitions for tuberculosis: 2021 update Nguyen Nhat Linh, Kerri Viney, Medea Gegia, Dennis Falzon, Philippe Glaziou, Katherine Floyd, Hazim Timimi, Nazir Ismail, Matteo Zignol, Tereza Kasaeva, Fuad Mirzayev Eur Respir J, 58 (2) 2100804; 10.1183/13993003.00804-2021 |    |
Pseudomonas aeruginosa and chronic lung allograft dysfunction: does evading an iceberg prevent the ship from sinking? Robin Vos, Anke Van Herck Eur Respir J, 58 (1) 2100041; 10.1183/13993003.00041-2021 |    |
Introduction H. GOOSSENS (Antwerp, Belgium)
|  |
Impact of appropriate diagnostics on the management of respiratory tract infections S. MALHOTRA-KUMAR (Antwerp, Belgium)
|  |
Economic aspects of enhanced testing strategies for respiratory diseases M. POSTMA (Groningen, Netherlands)
|  |
Evidence-based clinical algorithms for CAP: where do we stand? E. POLVERINO (Barcelona, Spain)
|  |
TB and COVID-19 – a dangerous new combination? Giovanni Battista Migliori (Varese (VA), Italy), Alberto García-Basteiro (Maputo, Mozambique)
Thursday, 22 July 2021 |   |
Management of MDR tuberculosis Marc Lipman (London, United Kingdom) & Raquel Duarte (Porto, Portugal)
Short video discussion: Thursday, 15 July 2021 |  |
Immunology: the immune response to mild and asymptomatic natural infection with SARS-CoV-2, and vaccination in healthy adults R. Boyton (London, United Kingdom)
|  |
PATS and ERS paediatric webinar: reducing the burden of CAP A. Irungu (PATS, Nairobi, Kenya), Stefan Unger (Edinburgh, United Kingdom), A. Goga (Pretoria, South Africa), Massimiliano Don (Udine, Italy)
Thursday, 15 April 2021 |  |
TB research and innovation in Latin America Selene Manga Eur Respir Rev, 30 (159) 200107; 10.1183/16000617.0107-2020 |    |
High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery Matthias Obenaus, Oliver Schildgen, Dirk Schürmann, Ann-Christin von Brünneck, Martin Janz, Ulrich Keller, Bernhard Gebauer, Johannes Schilling, Stefan Schwartz, Benedikt Weissbrich, Thomas Schneider, Jörg Hofmann, Stephan Mathas ERJ Open Res, 7 (2) 00060-2021; 10.1183/23120541.00060-2021 |    |
COVID-19 and complicated bacterial pneumonia in children Mohamad Kaddour, Marcelle Simeonovic, Joshua Osowicki, Sarah McNab, Catherine Satzke, Colin Robertson, Cattram Nguyen, Sebastian King, Shivanthan Shanthikumar ERJ Open Res, 7 (1) 00884-2020; 10.1183/23120541.00884-2020 |    |
The role of chest radiography in the diagnosis of bacteriologically confirmed pulmonary tuberculosis in hospitalised Xpert MTB/RIF-negative patients Wakjira Kebede, Gemeda Abebe, Esayas Kebede Gudina, Elias Kedir, Thuy Ngan Tran, Annelies Van Rie ERJ Open Res, 7 (1) 00708-2020; 10.1183/23120541.00708-2020 |    |
Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation Fabio Saliu, Giulia Rizzo, Alessandra Bragonzi, Lisa Cariani, Daniela M. Cirillo, Carla Colombo, Valeria Daccò, Daniela Girelli, Sara Rizzetto, Barbara Sipione, Cristina Cigana, Nicola I. Lorè ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020 |    |
Therapeutic drug monitoring and fluoroquinolones for multidrug-resistant tuberculosis Shashikant Srivastava, Tawanda Gumbo Eur Respir J, 57 (4) 2004454; 10.1183/13993003.04454-2020 |    |
Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies Thomas Maitre, Lorenzo Guglielmetti, Nicolas Veziris Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 |    |
Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore Liang En Wee, Edwin Philip Conceicao, Jing Yuan Tan, Jean Xiang Ying Sim, Indumathi Venkatachalam Eur Respir J, 57 (4) 2004493; 10.1183/13993003.04493-2020 |    |
Effective control of Staphylococcus aureus lung infection despite tertiary lymphoid structure disorganisation Lucile Regard, Clémence Martin, Jean-Luc Teillaud, Hélène Lafoeste, Hugues Vicaire, Maha Zohra Ladjemi, Emilie Ollame-Omvane, Sophie Sibéril, Pierre-Régis Burgel Eur Respir J, 57 (4) 2000768; 10.1183/13993003.00768-2020 |    |
Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Jennifer A. Bartell, Lea M. Sommer, Rasmus L. Marvig, Marianne Skov, Tacjana Pressler, Søren Molin, Helle Krogh Johansen Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 |    |
Wouldn't you like to know: are tertiary lymphoid structures necessary for lung defence? Jeffrey L. Curtis Eur Respir J, 57 (4) 2004352; 10.1183/13993003.04352-2020 |    |
Guideline-directed management of COVID-19: Do's and Don'ts Martin Kolb, Anh Tuan Dinh-Xuan, Laurent Brochard Eur Respir J, 57 (4) 2100753; 10.1183/13993003.00753-2021 |    |
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization Kerri Viney, Nguyen Nhat Linh, Medea Gegia, Matteo Zignol, Philippe Glaziou, Nazir Ismail, Tereza Kasaeva, Fuad Mirzayev Eur Respir J, 57 (4) 2100361; 10.1183/13993003.00361-2021 |    |
Phagosome-regulated mTOR signalling during sarcoidosis granuloma biogenesis Elliott D. Crouser, Landon W. Locke, Mark W. Julian, Sabahattin Bicer, Wolfgang Sadee, Peter White, Larry S. Schlesinger Eur Respir J, 57 (3) 2002695; 10.1183/13993003.02695-2020 |    |
Temporal airway microbiome changes related to ventilator-associated pneumonia in children Peter M. Mourani, Marci K. Sontag, Kayla M. Williamson, J. Kirk Harris, Ron Reeder, Chris Locandro, Todd C. Carpenter, Aline B. Maddux, Katherine Ziegler, Eric A.F. Simões, Christina M. Osborne, Lilliam Ambroggio, Matthew K. Leroue, Charles E. Robertson, Charles Langelier, Joseph L. DeRisi, Jack Kamm, Mark W. Hall, Athena F. Zuppa, Joseph Carcillo, Kathleen Meert, Anil Sapru, Murray M. Pollack, Patrick McQuillen, Daniel A. Notterman, J. Michael Dean, Brandie D. Wagner Eur Respir J, 57 (3) 2001829; 10.1183/13993003.01829-2020 |    |
Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015–2018: a record linkage study of the care cascade Joanna Nederby Öhd, Maria-Pia Hergens, Yauheni Luksha, Charlotte Buxbaum, Jad Shedrawy, Jerker Jonsson, Judith Bruchfeld, Knut Lönnroth Eur Respir J, 57 (3) 2002255; 10.1183/13993003.02255-2020 |    |
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, Stefan Niemann, Emmanuel André, Michel K. Kaswa, Elisa Tagliani, Andrea Cabibbe, Vanessa Mathys, Daniela Cirillo, Bouke C. de Jong, Leen Rigouts, Philip Supply Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020 |    |
Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics? Sagal Mohamed, Claudio U. Köser, Max Salfinger, Wladimir Sougakoff, Scott K. Heysell Eur Respir J, 57 (3) 2004077; 10.1183/13993003.04077-2020 |    |
How to treat NTM pulmonary disease: ATS/ERS/ESCMID/IDSA clinical practice guideline 2020 C. Lange (Borstel, Germany), C. Daley (Denver, United States of America), R.A. Floto (Cambridge (Cambridgeshire), United Kingdom)
|  |
Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control Henan Xin, Qi Jin, Lei Gao ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020 |    |
Pulmonary infection caused by Mycobacterium marinum in a patient with anorexia nervosa Kengo Oshima, Yukari Niinuma, Hajime Saito, Hiroaki Baba, Hajime Kanamori, Tetsuji Aoyagi, Koichi Tokuda, Mitsuo Kaku ERJ Open Res, 7 (1) 00782-2020; 10.1183/23120541.00782-2020 |    |
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 |    |
Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis Christophe Marguet, Véronique Houdouin, Isabelle Pin, Philippe Reix, Frédéric Huet, Marie Mittaine, Sophie Ramel, Nathalie Wizla-Derambure, Michel Abely, Marie-Laure Dalphin, Michael Fayon, Tiphaine Bihouée, Muriel Le Bourgeois, Eric Deneuville, Harriet Corvol, Muriel Laurans, Laure Couderc, Evelyne Leroux, Ludovic Lémée ERJ Open Res, 7 (1) 00513-2020; 10.1183/23120541.00513-2020 |    |
Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press.
Eur Respir J, 57 (3) 2002144; 10.1183/13993003.02144-2020 |   |
Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea Yong-Soo Kwon, Doosoo Jeon, Hyungseok Kang, Jae-Joon Yim, Tae Sun Shim Eur Respir J, 57 (3) 2003026; 10.1183/13993003.03026-2020 |    |
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China Lina Davies Forsman, Katarina Niward, Johanna Kuhlin, Xubin Zheng, Rongrong Zheng, Ran Ke, Chao Hong, Jim Werngren, Jakob Paues, Ulrika S.H. Simonsson, Erik Eliasson, Sven Hoffner, Biao Xu, Jan-Willem Alffenaar, Thomas Schön, Yi Hu, Judith Bruchfeld Eur Respir J, 57 (3) 2003463; 10.1183/13993003.03463-2020 |    |
Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection Frederik Trinkmann, Michael Müller, Alexandra Reif, Nicolas Kahn, Michael Kreuter, Franziska Trudzinski, Monika Eichinger, Claus-Peter Heussel, Felix J.F. Herth Eur Respir J, 57 (2) 2003002; 10.1183/13993003.03002-2020 |    |
Reversible pulmonary hypertension associated with multivisceral Whipple's disease Alice Camboulive, Etienne-Marie Jutant, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Charlotte Mussini, Jérémie Bénichou, Jean-Christophe Lagier, Marc Humbert, David Montani Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020 |    |
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go Martin Kolditz, Tobias Welte Eur Respir J, 57 (2) 2003778; 10.1183/13993003.03778-2020 |    |
What pulmonologists need to know about extrapulmonary tuberculosis Delphine Natali, Georges Cloatre, Christian Brosset, Pierre Verdalle, Alain Fauvy, Jean-Pierre Massart, Quy Vo Van, Nelly Gerard, Claudia C. Dobler, Philippe Hovette Breathe, 16 (4) 200216; 10.1183/20734735.0216-2020 |    |
Case 3 Samia Rached, Rodrigo Athanazio Eur Respir Monogr 2020; 88: 314-317 |   |
Cardiovascular side-effects of common antibiotics Francesco Amati, Marta Di Pasquale, Marcos I. Restrepo, Judith Marin-Corral, Stefano Aliberti, Francesco Blasi Eur Respir Monogr 2020; 88: 264-278 |   |
Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Raúl Méndez, Paula González-Jiménez, Laura Feced, Enrique Zaldívar, Rosario Menéndez Eur Respir Monogr 2020; 88: 212-228 |   |
Tuberculosis patients Cecile Magis-Escurra, Simon Tiberi, Onno Akkerman, Raquel Duarte Eur Respir Monogr 2021; 90: 181-192 |   |
Granulomatous and allied disorders Joanna Szram Eur Respir Monogr 2020; 89: 227-237 |   |
Silicosis and other silica-related lung disorders Deborah Helwen Yates, Anthony Rutledge Johnson Eur Respir Monogr 2020; 89: 150-175 |   |
The global perspective of occupational lung disease Mohamed F. Jeebhay Eur Respir Monogr 2020; 89: 1-18 |   |
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown? Steven J. Smith, John Busby, Liam G. Heaney, Paul E. Pfeffer, David J. Jackson, Freda Yang, Stephen J. Fowler, Andrew Menzies-Gow, Elfatih Idris, Thomas Brown, Robin Gore, Shoaib Faruqi, Paddy Dennison, James W. Dodd, Simon Doe, Adel H. Mansur, Radhika Priyadarshi, Joshua Holmes, Andrew Hearn, Hamsa Al-Aqqad, Lola Loewenthal, Angela Cooper, Lauren Fox, Mayurun Selvan, Michael G. Crooks, Alison Thompson, Daniel Higbee, Michelle Fawdon, Vishal Nathwani, LeanneJo Holmes, Rekha Chaudhuri ERJ Open Res, 7 (1) 00768-2020; 10.1183/23120541.00768-2020 |    |
Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion Jie Li, James B. Fink, Ahmad A. Elshafei, Laurel M. Stewart, Hannah J. Barbian, Sara H. Mirza, Lena Al-Harthi, David Vines, Stephan Ehrmann ERJ Open Res, 7 (1) 00519-2020; 10.1183/23120541.00519-2020 |    |
Challenges in understanding host genetics and severity of community-acquired pneumonia Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020 |    |
Higher interleukin-6 levels and changes in transforming growth factor-ß are associated with lung impairment in pulmonary tuberculosis Akshay N. Gupte, Sriram Selvaraju, Sanjay Gaikwad, Vidya Mave, Pavan Kumar, Subash Babu, Bruno B. Andrade, William Checkley, Robert Bollinger, Amita Gupta ERJ Open Res, 7 (1) 00390-2020; 10.1183/23120541.00390-2020 |    |
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact Yuji Yamamoto, Kazuyuki Tsujino, Tomoki Kuge, Fukuko Okabe, Takahiro Kawasaki, Takanori Matsuki, Hiroyuki Kagawa, Mari Miki, Keisuke Miki, Masahide Mori, Hiroshi Kida ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020 |    |
Collaborative tuberculosis/HIV activities in the European Region Gerard de Vries, Sarah van de Berg, Anke van Dam, Sayohat Hasanova, Manish Pareek, Marieke J. van der Werf, Daria N. Podlekareva ERJ Open Res, 7 (1) 00721-2020; 10.1183/23120541.00721-2020 |    |
Longitudinal non-cystic fibrosis trends of pulmonary Mycobacterium abscessus disease from 2010 to 2017: spread of the “globally successful clone” in Asia Aristine Cheng, Hsin-Yun Sun, Yi-Tzu Tsai, Po-Liang Lu, Susan Shin-Jung Lee, Yi-Tzu Lee, Yung-Chih Wang, Po-Yu Liu, Jung-Yien Chien, Po-Ren Hsueh, Shu-Yuan Chang, Un-In Wu, Wang-Huei Sheng, Yee-Chun Chen, Shan-Chwen Chang ERJ Open Res, 7 (1) 00191-2020; 10.1183/23120541.00191-2020 |    |
Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis Yen Jun Wong, Noorliza Mohd Noordin, Salmaan Keshavjee, Shaun Wen Huey Lee Eur Respir Rev, 30 (159) 200260; 10.1183/16000617.0260-2020 |    |
Influenza vaccination: protecting the most vulnerable Alex R. Tanner, Robert B. Dorey, Nathan J. Brendish, Tristan W. Clark Eur Respir Rev, 30 (159) 200258; 10.1183/16000617.0258-2020 |    |
Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Hannah Yejin Kim, Evan Ulbricht, Yu Kyung Ahn, Isabelle Sarah Gillooly, Kher Jing Lee, Jessica Lieu, William Nguyen, Sylvia Young, Jin-Gun Cho, Jan-Willem Alffenaar Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 |    |
Understanding new vaccines for SARS-CoV-2 and their regulation A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom)
Monday, 1 February 2021 |   |
An immunocompetent young man with diffuse pulmonary infiltrates João Pedro Steinhauser Motta, Isabella Barbosa Cleinman, Leonardo Palermo Bruno Breathe, 16 (4) 200165; 10.1183/20734735.0165-2020 |    |
2-year survival among elderly hospitalised for acute respiratory infection versus hip fracture: a useful comparison to raise awareness Antoine Guillon, Joseph P. Mizgerd, Leslie Grammatico-Guillon Eur Respir Rev, 29 (158) 200156; 10.1183/16000617.0156-2020 |    |
Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis Karen Keown, Alastair Reid, John E. Moore, Clifford C. Taggart, Damian G. Downey Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020 |    |
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment Xiaoying Gu, Fei Zhou, Yeming Wang, Guohui Fan, Bin Cao Eur Respir Rev, 29 (157) 200038; 10.1183/16000617.0038-2020 |    |
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Maria Sole Vallecoccia, Cristina Dominedò, Salvatore Lucio Cutuli, Ignacio Martin-Loeches, Antoni Torres, Gennaro De Pascale Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020 |    |
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis Ricardo J. José, Andrew Williams, Ari Manuel, Jeremy S. Brown, Rachel C. Chambers Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020 |    |
Rapid decline of seasonal influenza during the outbreak of COVID-19 Grant Young, Xiaohua Peng, Andre Rebaza, Santos Bermejo, Chang De, Lokesh Sharma, Charles S. Dela Cruz ERJ Open Res, 6 (3) 00296-2020; 10.1183/23120541.00296-2020 |    |
Metformin use and post-exposure incident tuberculosis: a nationwide tuberculosis-contact cohort study in Taiwan Sheng-Wei Pan, Jia-Yih Feng, Yung-Feng Yen, Fan-Yi Chuang, Hsiang-Shi Shen, Vincent Yi-Fong Su, Pei-Hung Chuang, Yu-Jiun Chan, Wei-Juin Su ERJ Open Res, 6 (3) 00050-2020; 10.1183/23120541.00050-2020 |    |
Diagnostic and economic evaluation of a point-of-care test for respiratory syncytial virus A. Joy Allen, Andrea Gonzalez-Ciscar, Clare Lendrem, Jana Suklan, Karen Allen, Ashley Bell, Frances Baxter, Stephen Crulley, Louise Fairlie, Danielle Hardy, Louise Johnston, Joanne McKenna, Nicole Richards, Gavin Shovlin, Clare Simmister, Sheila Waugh, Philip Woodsford, Sara Graziadio, Michael Power, A. John Simpson, Prashant Kumar, Katherine Eastham, Malcolm Brodlie ERJ Open Res, 6 (3) 00018-2020; 10.1183/23120541.00018-2020 |    |
Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPD Benjamin C. Hunt, Denise Stanford, Xin Xu, Jindong Li, Amit Gaggar, Steven M. Rowe, S. Vamsee Raju, W. Edward Swords ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020 |    |
Clinical manifestations and epidemiology of adolescent tuberculosis in Ukraine Silvia S. Chiang, Maria Dolynska, Natasha R. Rybak, Andrea T. Cruz, Omowunmi Aibana, Yana Sheremeta, Vasyl Petrenko, Andrii Mamotenko, Iana Terleieva, C. Robert Horsburgh, Helen E. Jenkins ERJ Open Res, 6 (3) 00308-2020; 10.1183/23120541.00308-2020 |    |
Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patients Pau Benito, Sergo Vashakidze, Shota Gogishvili, Keti Nikolaishvili, Albert Despuig, Nestan Tukvadze, Natalia Shubladze, Zaza Avaliani, Cristina Vilaplana ERJ Open Res, 6 (3) 00083-2020; 10.1183/23120541.00083-2020 |    |
Influence of age, sex and hospitalisation on the administration of tuberculosis medication: an evaluation of routine data from a German health insurer Jan F. Kersten, Stefanie Wobbe-Ribinski, Roland Diel, Albert Nienhaus, Anja Schablon ERJ Open Res, 6 (3) 00369-2019; 10.1183/23120541.00369-2019 |    |